PROS1 and infection: The S protein and the RBD fraction of Middle East respiratory syndrome coronavirus (MERS-CoV) have been used for the development of treatments, such as neutralizing anti-MERS-CoV, since they inhibit infection by blocking the virus from binding to the cell receptor or fusing with the cell membrane [42].